School of Medicine

Two grants totaling $30 million a year for three years support efforts to design vaccines and drugs for understudied virus families. WashU Medicine scientists are leading the efforts.

Two WashU faculty members, Benjamin Garcia and Rohit Pappu, have received annual awards from the American Society for Biochemistry and Molecular Biology.

Two professors of radiation oncology at Washington University School of Medicine in St. Louis — Clifford G. Robinson, MD, and Julie K. Schwarz, MD, PhD — have been named fellows of the American Society for Radiation Oncology.

Eric J. Huang, MD, PhD, a renowned physician-scientist specializing in neurodevelopmental and neurodegenerative diseases, has been named the Edward Mallinckrodt Professor and head of the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis.

James Walsh, MD, PhD, an assistant professor of ophthalmology and visual sciences at WashU Medicine, has received a four-year $350,000 career development award from Research to Prevent Blindness.

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, soon will open a newly constructed nine-story, 657,250-square-foot building on the Washington University Medical Campus. The state-of-the-art building will be dedicated exclusively to outpatient cancer care and will welcome its first patients Sept. 30.

Lindley B. Wall, MD, has been installed as the Jacqueline N. Baker and W. Randolph Baker Professor at WashU Medicine. Wall is a national leader in hand and upper-extremity surgeries for pediatric patients.

The Alpha Omega Alpha (AOA) Honor Medical Society chapter at WashU Medicine has announced 25 inductees for its Class of 2024.

Researchers at Washington University School of Medicine have received a $2.9 million grant from the National Institutes of Health (NIH) to conduct a clinical trial investigating whether inorganic nitrate can improve muscle function and exercise performance in patients with heart failure.

Opeolu Adeoye, MD, head of emergency medicine at WashU Medicine, led a national clinical trial that found two anti-coagulant medications are ineffective at improving post-treatment outcomes for stroke patients.